M1A.252 Drug-induced chronic gout, left hip

Name of the Condition

• Drug-Induced Chronic Gout, Left Hip

Summary

Drug-induced chronic gout, left hip is a form of arthritis affecting the left hip joint, resulting from prolonged elevated uric acid levels due to medication use. It leads to recurrent joint inflammation and potential tissue damage, characterized by persistent symptoms and may involve the formation of tophi (urate crystal deposits) in advanced stages.

Causes

This condition arises from medications that interfere with uric acid metabolism or excretion, causing accumulation in the blood. Over time, urate crystals deposit in the left hip joint and surrounding tissues, triggering inflammation. Common culprits include diuretics, low-dose aspirin, and certain chemotherapy agents.

Risk Factors

• Use of medications that increase uric acid levels (e.g., diuretics, low-dose aspirin)
• Prolonged exposure to urate-raising drugs
• Pre-existing hyperuricemia or gout history
• Renal impairment affecting drug clearance

Symptoms

• Recurrent episodes of intense left hip pain, often with swelling and redness
• Persistent warmth and tenderness in the affected hip
• Formation of tophi (hard, painless lumps) around the hip joint
• Stiffness and limited range of motion in the left hip
• Flare-ups triggered by stress, diet, or illness

Diagnosis

Diagnosis involves clinical evaluation, laboratory tests, and imaging. Blood tests assess uric acid levels, while joint fluid analysis may detect urate crystals. Imaging, such as X-rays or ultrasound, can reveal joint damage or tophi. Clinical history of medication use and symptom patterns supports the diagnosis.

Treatment Options

Treatment focuses on reducing uric acid levels and managing symptoms. Medications like urate-lowering agents (e.g., allopurinol) may be prescribed, along with anti-inflammatory drugs for pain relief. Lifestyle modifications, such as dietary changes and hydration, are often recommended. In severe cases, surgery to remove tophi or repair joint damage may be necessary.

Prognosis and Follow-Up

Prognosis depends on early intervention and adherence to treatment. With proper management, symptoms can be controlled, and joint damage may be minimized. Regular follow-up is essential to monitor uric acid levels, adjust medications, and assess joint function. Untreated cases may lead to progressive joint deterioration.

Complications

• Chronic joint damage and deformity
• Persistent pain and reduced mobility
• Development of tophi, which can ulcerate or become infected
• Increased risk of kidney stones or renal impairment

Lifestyle & Prevention

• Avoid medications known to raise uric acid levels when possible
• Maintain a balanced diet low in purines (e.g., limit red meat, seafood)
• Stay hydrated to support uric acid excretion
• Limit alcohol consumption, especially beer and spirits
• Engage in regular, low-impact exercise to preserve joint function

When to Seek Professional Help

Seek medical attention if you experience sudden, severe left hip pain, swelling, or redness, or if symptoms persist despite home care. Prompt evaluation is crucial to prevent joint damage. Contact a healthcare provider if you notice new lumps (tophi) around the hip or experience fever, as these may indicate infection.

Tips for Medical Coders

Document the specific laterality (left hip) and confirm the drug-induced etiology. Ensure clinical notes support the chronic nature of the condition and any associated tophi or joint damage. Verify that the code aligns with the documented diagnosis and treatment plan.